Detailed information for compound 878588

Basic information

Technical information
  • TDR Targets ID: 878588
  • Name: methyl 3-[2-(3-ethoxyphenyl)-4-oxo-1,3-thiazo lidin-3-yl]propanoate
  • MW: 309.381 | Formula: C15H19NO4S
  • H donors: 0 H acceptors: 2 LogP: 1.97 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCOc1cccc(c1)C1SCC(=O)N1CCC(=O)OC
  • InChi: 1S/C15H19NO4S/c1-3-20-12-6-4-5-11(9-12)15-16(13(17)10-21-15)8-7-14(18)19-2/h4-6,9,15H,3,7-8,10H2,1-2H3
  • InChiKey: LTUXBAWHIGANKY-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • methyl 3-[2-(3-ethoxyphenyl)-4-oxo-thiazolidin-3-yl]propanoate
  • 3-[2-(3-ethoxyphenyl)-4-oxo-3-thiazolidinyl]propanoic acid methyl ester
  • 3-[2-(3-ethoxyphenyl)-4-keto-thiazolidin-3-yl]propionic acid methyl ester
  • Oprea1_148573

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus multilocularis geranylgeranyl transferase type I beta subunit 0.0873 0.842 0.842
Trichomonas vaginalis protein farnesyltransferase alpha subunit/RAB geranylgeranyl transferase alpha subunit, putative 0.0972 1 1
Echinococcus granulosus protein farnesyltransferase alpha subunit 0.0972 1 1
Trypanosoma brucei protein farnesyltransferase beta subunit 0.0347 0 0.5
Echinococcus granulosus geranylgeranyl transferase type I beta subunit 0.0873 0.842 0.842
Echinococcus multilocularis protein farnesyltransferase alpha subunit 0.0972 1 1
Trichomonas vaginalis protein farnesyltransferase alpha subunit, putative 0.0972 1 1
Trichomonas vaginalis protein farnesyltransferase alpha subunit, putative 0.0972 1 1
Giardia lamblia Rab geranylgeranyltransferase 0.0972 1 1
Loa Loa (eye worm) prenyltransferase and squalene oxidase repeat family protein 0.0873 0.842 0.842
Loa Loa (eye worm) prenyltransferase alpha subunit repeat containing protein 0.0972 1 1
Loa Loa (eye worm) hypothetical protein 0.0972 1 1
Trypanosoma cruzi protein farnesyltransferase, putative 0.0347 0 0.5
Trichomonas vaginalis protein farnesyltransferase alpha subunit/RAB geranylgeranyl transferase alpha subunit, putative 0.072 0.5972 0.5972
Schistosoma mansoni geranylgeranyl transferase type I beta subunit 0.0873 0.842 0.842
Entamoeba histolytica protein farnesyltransferase alpha subunit, putative 0.0972 1 1
Trypanosoma cruzi protein farnesyltransferase, putative 0.0347 0 0.5
Trichomonas vaginalis geranylgeranyl transferase type I beta subunit, putative 0.0873 0.842 0.842
Plasmodium vivax prenyltransferase alpha subunit, putative 0.0972 1 1
Plasmodium falciparum protein farnesyltransferase subunit alpha 0.0972 1 1
Entamoeba histolytica geranylgeranyl transferase beta subunit 0.0873 0.842 0.842
Toxoplasma gondii hypothetical protein 0.072 0.5972 1
Schistosoma mansoni geranylgeranyl transferase type I beta subunit 0.0873 0.842 0.842
Schistosoma mansoni protein farnesyltransferase alpha subunit 0.0972 1 1
Brugia malayi Prenyltransferase and squalene oxidase repeat family protein 0.0873 0.842 0.842
Leishmania major farnesyltransferase beta subunit 0.0347 0 0.5

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.